An augmented trabeculectomy for neovascular glaucoma

Ophthalmic Surgery Lasers and Imaging

Volumn 42, Issue 3, 2011, Pages 196-201

  Dahan, Elie ^a   Ben Simon, Guy J ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MITOMYCIN C; NEOMYCIN; POLYMYXIN B; T-FLUX; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUGMENTED TRABECULECTOMY; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GLAUCOMA DRAINAGE IMPLANT; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; IRIDECTOMY; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RETINA VEIN OCCLUSION; SCLERA; SCLERECTOMY; TRABECULECTOMY; VISUAL ACUITY; VISUAL IMPAIRMENT; WILCOXON SIGNED RANKS TEST;

AGED; AGED, 80 AND OVER; ALKYLATING AGENTS; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE COMPLICATIONS; RETINAL VEIN OCCLUSION; SCLEROSTOMY; TONOMETRY, OCULAR; TRABECULECTOMY;

EID: 79958132651     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20110420-01     Document Type: Article

References (24)

1. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
2. Blanc JP, Molteno AC, Fuller JR, Bevin TH, Herbison P. Life expectancy of patients with neovascular glaucoma drained by Molteno implants. Clin Experiment Ophthalmol. 2004;32:360-363. (Pubitemid 39193851)
3. Das JC, Chaudhuri Z, Sharma P, Bhomaj S. The Ahmed Glaucoma Valve in refractory glaucoma: experiences in Indian eyes. Eye. 2005;19:183-190. (Pubitemid 40309504)
4. Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767-1776. (Pubitemid 32905930)
5. Schmack I, Dithmar S. Prophylactic pan-coagulation from ischemic central vein occlusions? Practicability of the results from the Central Vein Occlusion Study Group [article in German]. Ophthalmologe. 2003;100:1062-1066. (Pubitemid 38076001)
6. Susanna RJ, Latin American Glaucoma Society Investigators. Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. Br J Ophthalmol. 2003;87:994-998.
7. Chalam KV, Gandham S, Gupta S, Tripathi BJ, Tripathi RC. Pars plana modified Baerveldt implant versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmic Surg Lasers. 2002;33:383-393. (Pubitemid 44714244)
8. Murphy CC, Burnett CA, Spry PG, Broadway DC, Diamond JP. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol. 2003;87:1252-1257. (Pubitemid 37193917)
9. Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd:YAG laser cyclophotocoagulation: midterm results. Ophthalmology. 1992;99:1089-1094.
10. Benson MT, Nelson ME. Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol. 1990;74:103-105. (Pubitemid 20048546)
11. Delgado MF, Dickens CJ, Iwach AG, et al. Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology. 2003;110:895-899. (Pubitemid 36560485)
12. Pastor SA, Singh K, Lee DA, et al. Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology. 2001;108:2130-2138. (Pubitemid 33032791)
13. Feusier M, Roy S, Mermoud A. Deep sclerectomy combined with trabeculectomy in pediatric glaucoma. Ophthalmology. 2009;116:30-38.
14. Kayikcioglu OR, Emre S, Kaya Z. Trabeculectomy combined with deep sclerectomy and scleral flap suture tension adjustment under an anterior chamber maintainer: a new modification of trabeculectomy. Int Ophthalmol. 2010;30:271-277.
15. Dahan E, Ravinet E, Ben-Simon GJ, Mermoud A. Comparison of the efficacy and longevity of nonpenetrating glaucoma surgery with and without a new, nonabsorbable hydrophilic implant. Ophthalmic Surg Lasers Imaging. 2003;34:457-463. (Pubitemid 37386137)
16. Jungkim S, Gibran SK, Khan K, Murray A. External trabeculectomy with T-Flux implant. Eur J Ophthalmol. 2006;16:416-421. (Pubitemid 44049284)
17. Mandal AK, Majji AB, Mandal SP, et al. Mitomycin-C-augmented trabeculectomy for neovascular glaucoma: a preliminary report. Indian J Ophthalmol. 2002;50:287-293. (Pubitemid 36019805)
18. Hyung SM, Kim SK. Mid-term effects of trabeculectomy with mitomycin C in neovascular glaucoma patients. Korean J Ophthalmol. 2001;15:98-106.
19. Kumar N, Chang A, Beaumont P. Sympathetic ophthalmia following ciliary body laser cyclophotocoagulation for rubeotic glaucoma. Clin Experiment Ophthalmol. 2004;32:196-198. (Pubitemid 38618410)
20. Ochiai Y, Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol. 2002;46:249-253. (Pubitemid 34626632)
21. Yu XB, Sun XH, Dahan E, et al. Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38:6-14. (Pubitemid 46207322)
22. Branton MH, Kopp JB. TGF-beta and fibrosis. Microbes Infect. 1999;1:1349-1365.
23. Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666. (Pubitemid 19124123)
24. Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007;23:487-491. (Pubitemid 350202480)